About Galectin-12
Galectin-12 (LGALS12) is a protein
from Homo sapiens identified by UniProt accession
Q96DT0, 336 residues long.
MolForge cross-references it against 0 known binders and
39 disease associations.
Target properties
| Protein name | Galectin-12 |
| UniProt accession | Q96DT0 |
| Gene | LGALS12 |
| Organism | Homo sapiens |
| Length | 336 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (39)
Diseases linked to this target (Open Targets).
- hypertrophic cardiomyopathy · score 0.06
- atherosclerosis · score 0.05
- CIDEC-related familial partial lipodystrophy · score 0.05
- obesity due to melanocortin 4 receptor deficiency · score 0.04
- AKT2-related familial partial lipodystrophy · score 0.04
- PPARG-related familial partial lipodystrophy · score 0.04
- LIPE-related familial partial lipodystrophy · score 0.04
- PLIN1-related familial partial lipodystrophy · score 0.04
- familial partial lipodystrophy, Dunnigan type · score 0.04
- mandibuloacral dysplasia · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96DT0-F1 | alphafold | PREDICTED | 88.57 | — |
Amino-acid sequence (336 residues)
MSQPSGGRAP GTRIYSWSCP TVMSPGEKLD PIPDSFILQP PVFHPVVPYV TTIFGGLHAG KMVMLQGVVP LDAHRFQVDF QCGCSLCPRP DIAFHFNPRF HTTKPHVICN TLHGGRWQRE ARWPHLALRR GSSFLILFLF GNEEVKVSVN GQHFLHFRYR LPLSHVDTLG IFGDILVEAV GFLNINPFVE GSREYPAGHP FLLMSPRLEV PCSHALPQGL SPGQVIIVRG LVLQEPKHFT VSLRDQAAHA PVTLRASFAD RTLAWISRWG QKKLISAPFL FYPQRFFEVL LLFQEGGLKL ALNGQGLGAT SMNQQALEQL RELRISGSVQ LYCVHS
Explore Galectin-12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets